Safety and Efficacy of Mobic Inj. (Meloxicam) for the Patients With OA or RA: Observational Study

INCLUSION CRITERIA: diagnosed as osteoarthritis and rheumatoid arthritis EXCLUSION CRITERIA: 1. Known hypersensitivity to meloxicam 2. Cross hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs 3. Symptoms of asthma, rhinitis, angioneurotic edema, or urticaria following the administration of aspirin or other NSAIDs 4. Active peptic ulceration 5. Severe hepatic failure. 6. Non-dialysed severe renal insufficiency 7. Children and adolescents aged 15 years or less 8. Pregnancy or breastfeeding